Pulmonary function test → assessment of lung function
Used for - dDx restrictive vs. obstructive diseases
Restrictive disease (idiopathic p fibrosis, sarcoid)
Obstructive (asthma, COPD)
Preop and Post tx to ✓ effectiveness
Purposes of PFT
Dx sx diseases - chronic dyspnea, cough, unexplained hypocapnia
Screen for early aSx pathology
Prognosis fo known pathology
Monitor response to Tx
PFT represents
Patency Airways - Large and Small Airways
Parenchyma - Alveoli/interstitium
Pulmonary Vasculature
Bellows/Pump Mechanism
Diaphragm
Chest Wall
Neural Control of Ventilation
dDx
Obstructive Lung Disease
COPD (chronic bronchitis ← → emphysema)
Asthma
Bronchiectasis
Cystic fibrosis
Restrictive Lung Disease
Interstitial lung disease (e.g. pulmonary fibrosis, sarcoidosis)
Chest wall pathology (e.g. kyphosis, scoliosis)
Obesity
Neuromuscular disease (e.g. ALS, muscular dystrophy)
Pulmonary Vascular Disease
Primary pulmonary hypertension
Chronic thromboembolic disease
Types of PFTs
Standard PFTs
Spirometry - (including flow-volume loop) - measure of airflow - dx obstruction
Lung Volumes - dx restrictive
Diffusing Capacity of Carbon Monoxide (DLco) → dx pulmonary vascular pathology
Specialized PFTs
Arterial Blood Gas
Exercise Oximetry
6 Minute Walk Test
Peak Flow
Maximum Inspiratory and
Expiratory Pressures A
Static volume (lung volumes)
The amount of air after deep inspiration = total lung capacity
Breath out totally = vital capacity
And left with residual volume
normal values = ± 80% - 120% or 95
Spirometry - measure the airflow
Forced vital capacity (FVC) = the amount of air exhaled = VC
FVC1 = the amount of air exhaled in the first second